FL
PFE icon

FreeGulliver LLC’s Pfizer PFE Stock Holding History

FreeGulliver LLC’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$201K Buy
+8,360
New +$219K 0.07% 115
2025
Q3 		– Sell
-15,451
Closed -$375K – 114
2025
Q2 		$375K Sell
15,451
-175
-1% -$4.08K 0.17% 57
2025
Q1 		$396K Buy
15,626
+104
+0.7% +$2.72K 0.2% 52
2024
Q4 		$412K Sell
15,522
-840
-5% -$22.8K 0.2% 48
2024
Q3 		$474K Buy
16,362
+708
+5% +$20.7K 0.28% 41
2024
Q2 		$438K Buy
15,654
+114
+0.7% +$3.14K 0.3% 37
2024
Q1 		$431K Hold
15,540
– – 0.38% 31
2023
Q4 		$447K Buy
+15,540
New +$470K 0.59% 21

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

FreeGulliver LLC's PFE Position: Q2 2026 in Review

FreeGulliver LLC opened a new position in Pfizer (PFE) in Q2 2026: 8,360 shares worth $201K. The stake represents 0.07% of the portfolio and ranks #115 among its holdings. This is a return to the name: FreeGulliver LLC previously reported a position in PFE as recently as Q2 2025.

FreeGulliver LLC first reported a position in PFE in Q4 2023 and has held it in 8 quarters since. The position peaked at $474K in Q3 2024. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • FreeGulliver LLC held 8,360 shares of Pfizer worth $201K as of Q2 2026.
  • Pfizer was a new FreeGulliver LLC position in Q2 2026.
  • Pfizer made up 0.07% of FreeGulliver LLC's portfolio in Q2 2026, its #115 holding.
  • FreeGulliver LLC first reported a position in Pfizer in Q4 2023 and has held it in 8 quarters since.
  • FreeGulliver LLC's Pfizer position peaked at $474K in Q3 2024.
  • 2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on FreeGulliver LLC's 13F filing for Q2 2026, filed 11 Aug 2026.